Document is current
Any future updates will be listed below
-
Authors
Ehrmann, Alena Sophie
Quijada-Álamo, Miguel
Close, Viola
Guo, Min
Carracoi, Valentina
Pérez-Carretero, Claudia
Corchete, Luis Antonio https://orcid.org/0000-0003-4577-8599
Friedrich, Tobias
Giaimo, Benedetto Daniele https://orcid.org/0000-0003-0384-325X
Yosifov, Deyan Yordanov https://orcid.org/0000-0002-5473-4398
Bloehdorn, Johannes https://orcid.org/0000-0003-1433-9702
Rodríguez-Sánchez, Alberto
Tausch, Eugen
Schneider, Christof
Döhner, Hartmut https://orcid.org/0000-0003-2116-5536
Kietzmann, Thomas
Borggrefe, Tilman https://orcid.org/0000-0003-4325-5452
Stilgenbauer, Stephan https://orcid.org/0000-0002-6830-9296
Oswald, Franz https://orcid.org/0000-0002-2923-5765
Hernández-Rivas, Jesús-María
Mertens, Daniel https://orcid.org/0000-0003-0227-7188
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe (70114291, 70114289)
Deutsche Forschungsgemeinschaft (SFB1074 projects B1 and B2, SFB1074 project A3, SFB1506 project A5)
Fundación Española de Hematología y Hemoterapia
Jane ja Aatos Erkon Säätiö
Sigrid Juséliuksen Säätiö
Biocenter Oulu spearhead projects
- License Information
-
More Information
Article History
Received: 2 October 2024
Revised: 7 April 2025
Accepted: 24 April 2025
First Online: 2 June 2025
Competing interests
: The authors declare no competing interests.
: Collection and usage of primary cells from CLL patients has been approved by the Ethics Committee of Ulm University (Vote 242/20). All methods were performed in accordance with the relevant guidelines and regulations.
: All patients had given written informed consent to the collection and usage of their cells for research purposes according to the Declaration of Helsinki.
